Cargando…
The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design
The ribosomal P70 S6 kinases play a crucial role in PI3K/mTOR regulated signalling pathways and are therefore potential targets for the treatment of a variety of diseases including diabetes and cancer. In this study we describe the identification of three series of chemically distinct S6K1 inhibitor...
Autores principales: | Couty, Sylvain, Westwood, Isaac M., Kalusa, Andrew, Cano, Celine, Travers, Jon, Boxall, Kathy, Chow, Chiau Ling, Burns, Sam, Schmitt, Jessica, Pickard, Lisa, Barillari, Caterina, McAndrew, P. Craig, Clarke, Paul A., Linardopoulos, Spiros, Griffin, Roger J., Aherne, G. Wynne, Raynaud, Florence I., Workman, Paul, Jones, Keith, van Montfort, Rob L.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858552/ https://www.ncbi.nlm.nih.gov/pubmed/24072592 |
Ejemplares similares
-
Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer
por: Clarke, Paul A., et al.
Publicado: (2019) -
Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2
por: Silva-Santisteban, M. Cris, et al.
Publicado: (2013) -
Structure-Based Design of
Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine
Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)
por: Naud, Sébastien, et al.
Publicado: (2013) -
Finding the needle in the haystack: why high-throughput screening is good for your health
por: Aherne, G Wynne, et al.
Publicado: (2002) -
Structure-based drug design: aiming for a perfect fit
por: van Montfort, Rob L.M., et al.
Publicado: (2017)